O'Brien, Travis J <br/><br/>
First report of warfarin dose requirements in patients possessing the CYP2C9*12 allele.  [electronic resource] 

 -  Clinica chimica acta; international journal of clinical chemistry  Sep 2013 
 - 73-5 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1873-3492 
<br/><br/><label>Standard No.: </label>10.1016/j.cca.2013.05.008  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Aged, 80 and over<br/>Alleles<br/>Amino Acid Substitution<br/>Anticoagulants--metabolism<br/>Apolipoproteins E--genetics<br/>Aryl Hydrocarbon Hydroxylases--genetics<br/>Base Sequence<br/>Biotransformation<br/>Cytochrome P-450 CYP2C9<br/>Drug Dosage Calculations<br/>Female<br/>Genotype<br/>Genotyping Techniques<br/>Heterozygote<br/>Humans<br/>Male<br/>Middle Aged<br/>Molecular Sequence Data<br/>Mutation<br/>Thromboembolism--enzymology<br/>Vitamin K Epoxide Reductases--genetics<br/>Warfarin--metabolism